Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01792050
Recruitment Status : Unknown
Verified March 2016 by NewLink Genetics Corporation.
Recruitment status was:  Active, not recruiting
First Posted : February 15, 2013
Last Update Posted : March 15, 2016
Information provided by (Responsible Party):
NewLink Genetics Corporation

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2016
  Study Completion Date : No date given